Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Ralf A. Benndorf

Clinical Pharmacology Unit

Institute of Experimental and Clinical Toxicology and Pharmacology

University Hospital Hamburg-Eppendorf

Hamburg

Germany

[email]@uke.uni-hamburg.de

Name/email consistency: high

[Claim this account]

Affiliations

Clinical Pharmacology Unit, Institute of Experimental and Clinical Toxicology and Pharmacology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. 2006 - 2009
Institut für Experimentelle und Klinische Pharmakologie, Universitätsklinikum Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany. 2003

References

Angiotensin II type 2 receptor deficiency aggravates renal injury and reduces survival in chronic kidney disease in mice. Benndorf, R.A., Krebs, C., Hirsch-Hoffmann, B., Schwedhelm, E., Cieslar, G., Schmidt-Haupt, R., Steinmetz, O.M., Meyer-Schwesinger, C., Thaiss, F., Haddad, M., Fehr, S., Heilmann, A., Helmchen, U., Hein, L., Ehmke, H., Stahl, R.A., Böger, R.H., Wenzel, U.O. Kidney Int. (2009) [Pubmed]
Isoprostanes inhibit vascular endothelial growth factor-induced endothelial cell migration, tube formation, and cardiac vessel sprouting in vitro, as well as angiogenesis in vivo via activation of the thromboxane A(2) receptor: a potential link between oxidative stress and impaired angiogenesis. Benndorf, R.A., Schwedhelm, E., Gnann, A., Taheri, R., Kom, G., Didié, M., Steenpass, A., Ergün, S., Böger, R.H. Circ. Res. (2008) [Pubmed]
Mobilization of putative high-proliferative-potential endothelial colony-forming cells during antihypertensive treatment in patients with essential hypertension. Benndorf, R.A., Gehling, U.M., Appel, D., Maas, R., Schwedhelm, E., Schlagner, K., Silberhorn, E., Hossfeld, D.K., Rogiers, X., Böger, R. Stem Cells Dev. (2007) [Pubmed]
Telmisartan improves endothelial function in patients with essential hypertension. Benndorf, R.A., Appel, D., Maas, R., Schwedhelm, E., Wenzel, U.O., Böger, R.H. J. Cardiovasc. Pharmacol. (2007) [Pubmed]
Telmisartan improves insulin sensitivity in nondiabetic patients with essential hypertension. Benndorf, R.A., Rudolph, T., Appel, D., Schwedhelm, E., Maas, R., Schulze, F., Silberhorn, E., Böger, R.H. Metab. Clin. Exp. (2006) [Pubmed]
Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells. Benndorf, R., Böger, R.H., Ergün, S., Steenpass, A., Wieland, T. Circ. Res. (2003) [Pubmed]

The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.